These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 23885265)

  • 1. The MDM2-p53 pathway revisited.
    Nag S; Qin J; Srivenugopal KS; Wang M; Zhang R
    J Biomed Res; 2013 Jul; 27(4):254-71. PubMed ID: 23885265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tumor protein 53 mutations in common human cancers and targeting the murine double minute 2-p53 interaction for cancer therapy.
    Hamzehloie T; Mojarrad M; Hasanzadeh Nazarabadi M; Shekouhi S
    Iran J Med Sci; 2012 Mar; 37(1):3-8. PubMed ID: 23115424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the MDM2-p53 interaction for cancer therapy.
    Shangary S; Wang S
    Clin Cancer Res; 2008 Sep; 14(17):5318-24. PubMed ID: 18765522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivation of p53 by a specific MDM2 antagonist (MI-43) leads to p21-mediated cell cycle arrest and selective cell death in colon cancer.
    Shangary S; Ding K; Qiu S; Nikolovska-Coleska Z; Bauer JA; Liu M; Wang G; Lu Y; McEachern D; Bernard D; Bradford CR; Carey TE; Wang S
    Mol Cancer Ther; 2008 Jun; 7(6):1533-42. PubMed ID: 18566224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient activation of p53 pathway in A549 cells exposed to L2, a novel compound targeting p53-MDM2 interaction.
    Zhang L; Zhang J; Hu C; Cao J; Zhou X; Hu Y; He Q; Yang B
    Anticancer Drugs; 2009 Jul; 20(6):416-24. PubMed ID: 19579266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDM2 oncogene as a novel target for human cancer therapy.
    Zhang ; Wang H
    Curr Pharm Des; 2000 Mar; 6(4):393-416. PubMed ID: 10788589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53-MDM2 Pathway: Evidences for A New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia.
    Trino S; De Luca L; Laurenzana I; Caivano A; Del Vecchio L; Martinelli G; Musto P
    Front Pharmacol; 2016; 7():491. PubMed ID: 28018226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine.
    Qin JJ; Li X; Hunt C; Wang W; Wang H; Zhang R
    Genes Dis; 2018 Sep; 5(3):204-219. PubMed ID: 30320185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction.
    Soares J; Pereira NA; Monteiro Â; Leão M; Bessa C; Dos Santos DJ; Raimundo L; Queiroz G; Bisio A; Inga A; Pereira C; Santos MM; Saraiva L
    Eur J Pharm Sci; 2015 Jan; 66():138-47. PubMed ID: 25312347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment.
    Urso L; Calabrese F; Favaretto A; Conte P; Pasello G
    Crit Rev Oncol Hematol; 2016 Jan; 97():220-30. PubMed ID: 26358421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UBTD1 induces cellular senescence through an UBTD1-Mdm2/p53 positive feedback loop.
    Zhang XW; Wang XF; Ni SJ; Qin W; Zhao LQ; Hua RX; Lu YW; Li J; Dimri GP; Guo WJ
    J Pathol; 2015 Mar; 235(4):656-67. PubMed ID: 25382750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents.
    Nayak SK; Khatik GL; Narang R; Monga V; Chopra HK
    Curr Cancer Drug Targets; 2018; 18(8):749-772. PubMed ID: 28669344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological activation of the p53 pathway by nutlin-3 exerts anti-tumoral effects in medulloblastomas.
    Künkele A; De Preter K; Heukamp L; Thor T; Pajtler KW; Hartmann W; Mittelbronn M; Grotzer MA; Deubzer HE; Speleman F; Schramm A; Eggert A; Schulte JH
    Neuro Oncol; 2012 Jul; 14(7):859-69. PubMed ID: 22591662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdm2 inhibitor Nutlin-3a induces p53-mediated apoptosis by transcription-dependent and transcription-independent mechanisms and may overcome Atm-mediated resistance to fludarabine in chronic lymphocytic leukemia.
    Kojima K; Konopleva M; McQueen T; O'Brien S; Plunkett W; Andreeff M
    Blood; 2006 Aug; 108(3):993-1000. PubMed ID: 16543464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mdm2 proto-oncogene.
    Haines DS
    Leuk Lymphoma; 1997 Jul; 26(3-4):227-38. PubMed ID: 9322885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The oncoprotein HBXIP promotes human breast cancer growth through down-regulating p53 via miR-18b/MDM2 and pAKT/MDM2 pathways.
    Li H; Wang Z; Jiang M; Fang RP; Shi H; Shen Y; Cai XL; Liu Q; Ye K; Fan SJ; Zhang WY; Ye LH
    Acta Pharmacol Sin; 2018 Nov; 39(11):1787-1796. PubMed ID: 30181579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine double minute 2: p53-independent roads lead to genome instability or death.
    Bouska A; Eischen CM
    Trends Biochem Sci; 2009 Jun; 34(6):279-86. PubMed ID: 19447627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?
    Qi SM; Cheng G; Cheng XD; Xu Z; Xu B; Zhang WD; Qin JJ
    Front Cell Dev Biol; 2020; 8():233. PubMed ID: 32300595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new twist in the feedback loop: stress-activated MDM2 destabilization is required for p53 activation.
    Stommel JM; Wahl GM
    Cell Cycle; 2005 Mar; 4(3):411-7. PubMed ID: 15684615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the p53-MDM2 interaction by adenovirus delivery of ribosomal protein L23 stabilizes p53 and induces cell cycle arrest and apoptosis in gastric cancer.
    Zhang Y; Shi Y; Li X; Du W; Luo G; Gou Y; Wang X; Guo X; Liu J; Ding J; Wu K; Fan D
    J Gene Med; 2010 Feb; 12(2):147-56. PubMed ID: 20020415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.